ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 10 of 25
Up
JMBS 2022, 7(4): 69–75
https://doi.org/10.26693/jmbs07.04.069
Clinical Medicine

Correlation Relations between Endothelial Monocyte Activating Polypeptide-ІІ and Troponin I in Patients with Comorbid Pathology

Feldman D. A.
Abstract

The purpose of the study was to investigate the correlation between the levels of endothelial monocyte activating polypeptide-ІІ and troponin I in patients with acute myocardial infarction and diabetes mellitus type 2. Materials and methods. 120 patients took part in the study: 1st group – acute myocardial infarction patients with diabetes mellitus type 2 (n=70), 2nd group – patients with acute myocardial infarction (n=50). The control group included 20 practically healthy people. According to the orders of the Ministry of Health of Ukraine, the patients were diagnosed with acute myocardial infarction and diabetes mellitus type 2. All patients underwent laboratory and instrumental examinations on the first day of acute myocardial infarction. The level of endothelial monocyte activating polypeptide-ІІ (EMAP-II) was determined using the "Human Endothelial monocyte activating polypeptide-ІІ ELISA KIT" test system. Statistical processing of the research results was carried out using the "Statistica 6.0" software package. Results and discussion. The average level of endothelial monocyte activating polypeptide-ІІ on the first day of acute myocardial infarction was: in patients who were part of the 1st group – 4.54±0.331 ng/ml; 2nd – 2.74±0.21 ng/ml; in the control group – 1.1±0.037 ng/ml (р<0.05). The average level of troponin I on the first day of acute myocardial infarction was: in patients of the 1st group – 4.89±2.46 ng/ml; 2nd – 2.67±2.06 ng/ml; in the control group – 0.06±0.04 ng/ml (р˂0.00001). In the course of the correlation analysis, a direct significant correlation was found between the levels of endothelial monocyte activating polypeptide-ІІ and troponin I (r=0.700; p˂0.05). Correlation between the levels of endothelial monocyte activating polypeptide-ІІ and troponin I in patients of the 1st group was: between these indicators in patients who had a mild form of diabetes mellitus type 2 – a direct strong correlation (r=0.900; p˂0.05); moderate – a direct noticeable correlation (r=0.439; p>0.05); difficult – direct strong correlation (r=0.754; p˂0.05). Conclusion. Endothelial monocyte activating polypeptide-ІІ has a high diagnostic value in patients with acute myocardial infarction with diabetes mellitus type 2. When patients with the above-mentioned diseases were combined, the level of this indicator was significantly higher than in patients with isolated acute myocardial infarction and the control group (p<0.05). Troponin I hyperactivity was detected in patients with acute myocardial infarction, especially when combined with diabetes mellitus type 2 (p<0.00001). When determining the above-mentioned indicators in patients of the 1st group according to the forms of diabetes mellitus type 2, a directly proportional dependence with these parameters was found (р<0.05). In the course of the correlation analysis, a direct significant correlation between the levels of endothelial monocyte activating polypeptide-ІІ and troponin I was revealed (р˂0.05)

Keywords: endothelial monocyte activating polypeptide-ІІ, troponin I, comorbid pathology, acute myocardial infarction, diabetes mellitus type 2

Full text: PDF (Ukr) 283K

References
  1. Xu T, Ding W, Ji X, Ao X, Liu Y, Yu W, Wang J. Oxidative Stress in Cell Death and Cardiovascular Diseases. Oxid Med Cell Longev. 2019 Nov 4;2019:9030563. PMID: 31781356. PMCID: PMC6875219. doi: 10.1155/2019/9030563
  2. Francula-Zaninovic S, Nola IA. Management of Measurable Variable Cardiovascular Disease' Risk Factors. Curr Cardiol Rev. 2018;14(3):153-163. PMID: 29473518. PMCID: PMC6131408. doi: 10.2174/1573403X14666180222102312
  3. Vanuzzo D, Pilotto L, Mirolo R, Pirelli S. Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation. G Ital Cardiol (Rome). 2008 Apr; 9(4 Suppl 1):6S-17S. PMID: 18773746
  4. Jia G, Aroor AR, Jia С, Sowers JR. Endothelial cell senescence in aging-related vascular dysfunction. Biochim Biophys Acta Mol Basis Dis. 2019 Jul 1;1865(7):1802-1809. PMID: 31109450. doi: 10.1016/j.bbadis.2018.08.008
  5. Love KM, Barrett EJ, Malin SK, Reusch JEB, Regensteiner JG, Liu Z. Diabetes pathogenesis and management: the endothelium comes of age. J Mol Cell Biol. 2021 Oct 21;13(7):500-512. PMID: 33787922. PMCID: PMC8530521. doi: 10.1093/jmcb/mjab024
  6. Mohyl'nyts'ka LA. Serum levels of endothelial monocyte-activating polypeptide-II in type 2 diabetes mellitus. Fiziol Zh (1994). 2014;60(1):84-90. PMID: 24809179
  7. Chaulin AM. The Importance of Cardiac Troponin Metabolism in the Laboratory Diagnosis of Myocardial Infarction (Comprehensive Review). Biomed Res Int. 2022 Mar 30;2022:6454467. PMID: 35402607. PMCID: PMC8986381. doi: 10.1155/2022/6454467
  8. Chaulin AM. Biology of Cardiac Troponins: Emphasis on Metabolism. Biology (Basel). 2022 Mar 11;11(3):429. PMID: 35336802. PMCID: PMC8945489. doi: 10.3390/biology11030429
  9. Katrukha IA. Human cardiac troponin complex. Structure and functions. Biochem. 2013 Dec;78(13):1447-65. PMID: 24490734. doi: 10.1134/S0006297913130063
  10. Mair J, Lindahl B, Hammarsten O, Müller C, Giannitsis E, Huber K, et al. How is cardiac troponin released from injured myocardium? Eur Heart J Acute Cardiovasc Care. 2018 Sep;7(6):553-560. PMID: 29278915. doi: 10.1177/2048872617748553
  11. Mіnіsterstvo ohoroni zdorov’ya Ukraїni, Nakaz № 455. Unіfіkovanij klіnіchnij protokol ekstrenoї, pervinnoї, vtorinnoї (specіalіzovanoї) ta tretinnoї (visokospecіalіzovanoї) medichnoї dopomogi ta medichnoї reabіlіtacії «Gostrij koronarnij sindrom z elevacіeyu segmenta ST» [Unified clinical protocol of emergency, primary, secondary (specialized) and tertiary (highly specialized) medical care and medical rehabilitation "Acute coronary syndrome with elevation of the ST segment"]. K: Ministry of Health of Ukraine; 2014 July 2. p. 92. [Ukrainian]
  12. Mogylnytska LA. Endothelial monocyte-activating polypeptide-II: properties, functions, and pathogenetic significance. Fiziol Zh (1994). 2015;61(1):102-11. PMID: 26040042. doi: 10.15407/fz61.01.102
  13. Adly ААМ, Ismail ЕА, Tawfik LM, Ebeid FSE, Hassan AAS. Endothelial monocyte activating polypeptide II in children and adolescents with type 1 diabetes mellitus: Relation to micro-vascular complications. Cytokine. 2015 Dec;76(2):156-162. PMID: 26142824. doi: 10.1016/j.cyto.2015.06.006
  14. Keller T, Zeller T, Ojeda F, Tzikas S, Lillpopp L, Sinning C, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA. 2011 Dec 28;306(24):2684-93. PMID: 22203537. doi: 10.1001/jama.2011.1896
  15. Body R, Morris N, Collinson P. Single test rule-out of acute myocardial infarction using the limit of detection of a new high-sensitivity troponin I assay. Clin Biochem. 2020 Apr;78:4-9. PMID: 32135083. doi: 10.1016/j.clinbiochem.2020.02.014